Scholars converged at Cornell to talk about lessons policymakers and elected officials could glean from their research into the COVID pandemic to help deal with the next public health emergency.
An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how – and where – the psychedelic compound rewires the connections in the brain.
In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine and an oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, is working on personalizing treatment for pancreatic cancer, which is often diagnosed too late.
To equip astronauts with health choices for future missions, a Cornell postdoctoral fellow is leading research with AstroCup, a group that recently tested two menstrual cups in spaceflight as payload on an uncrewed rocket flight.
Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.
